Skip to content
Screener

Carlsmed, Inc. CARL Total Liabilities & Equity

Total Liabilities & Equity at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$201.06B+4.0%
Stryker logo
StrykerSYK
$47.93B+3.5%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$873.02M+4.3%
Globus Medical logo
Globus MedicalGMED
$5.49B+10.6%
Alphatec Holdings logo
Alphatec HoldingsATEC
$799.48M+1.8%
Medtronic logo
MedtronicMDT
$93.03B+1.5%

Other financials

Income statement

See full
Revenue$18.9M+56.7%
Gross profit$14.5M+64.0%
Operating income-$11.0M-69.7%
Net income-$10.5M-55.3%
EPS (diluted)-$0.39+73.5%

Balance sheet

See full
Cash & equivalents$46.2M+38.2%
Total debt$21.9M+23.8%
Total equity$84.2M+201%
Total assets$118.2M+122%

Cash flow

See full
Operating cash flow-$7.4M-4.5%
CapEx$121.0K-63.0%
Free cash flow-$7.5M-1.5%

Valuation

See full
Market cap$377.32M+11.1%
Enterprise value$353M
P/S

Profitability

See full
Gross margin76.6%+2.6pp
Operating margin-61.1%-3.1pp
Net margin-57.4%-6.2pp
FCF margin-54.6%-10.6pp

Returns & leverage

See full
Return on equity-6,196.9%
Debt / equity0.3×
Current ratio8.8×+4.0×

Where this comes from

Reported directly by Carlsmed, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: Carlsmed, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:10 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001794546-26-000016
Line itemJune 30, 2026December 31, 2025
Stockholders’ equity:
Preferred stock, $0.00001 par value; 10,000,000 shares authorized and zero shares issued and outstanding as of June 30, 2026 and December 31, 2025
Common stock, $0.00001 par value; 600,000,000 shares authorized, 27,267,575 shares issued, and 27,225,759 shares outstanding as of June 30, 2026; 600,000,000 shares authorized, 26,664,243 shares issued, and 26,604,505 shares outstanding as of December 31, 2025
Additional paid-in capital204,274199,674
Accumulated deficit(120,011)(100,805)
Accumulated other comprehensive loss(17)
Total stockholders’ equity84,24698,869
Total liabilities and stockholders’ equity$118,202$130,120

Item 1. Financial Statements.

FAQ

What is Carlsmed, Inc.'s total liabilities & equity?
Carlsmed, Inc. (CARL) reported total liabilities & equity of $118.2M in Q2 2026.
How has Carlsmed, Inc.'s total liabilities & equity changed year-over-year?
Carlsmed, Inc.'s total liabilities & equity increased by 121.9% year-over-year, from $53.27M to $118.2M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about Carlsmed, Inc.'s total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude